Potential targets for glucagon-like peptide 2 (GLP-2) in the rat: distribution and binding of i.v. injected (125)I-GLP-2.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Peptides

• Publication date

  2000-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0196-9781(00)00305-3PMID 11068098
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dipeptidyl peptidase IV inhibition enhances the intestinotrophic effect of glucagon-like peptide-2 in rats and mice.

  2000cited by this paper
• Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon

  2000cited by this paper
• Structure, measurement, and secretion of human glucagon-like peptide-2.

  2000cited by this paper
• Enzymatic- and renal-dependent catabolism of the intestinotropic hormone glucagon-like peptide-2 in rats.

  2000cited by this paper
• Impaired meal stimulated glucagon-like peptide 2 response in ileal resected short bowel patients with intestinal failure

  1999cited by this paper
• Human [Gly2]GLP-2 reduces the severity of colonic injury in a murine model of experimental colitis.

  1999cited by this paper
• Glucagonlike peptide-2 enhances small intestinal absorptive function and mucosal mass in vivo.

  1999cited by this paper
• Diabetic intestinal growth adaptation and glucagon-like peptide 2 in the rat: effects of dietary fibre

  1999cited by this paper
• Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2.

  1999cited by this paper
• Secretion of the intestinotropic hormone glucagon-like peptide 2 is differentially regulated by nutrients in humans.

  1999cited by this paper
• Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes.

  1998cited by this paper
• GLP-2 augments the adaptive response to massive intestinal resection in rat.

  1998cited by this paper
• Enteroglucagon.

  1997cited by this paper
• Prevention of parenteral nutrition-induced gut hypoplasia by coinfusion of glucagon-like peptide-2.

  1997cited by this paper
• Upregulation of SGLT-1 transport activity in rat jejunum induced by GLP-2 infusion in vivo.

  1997cited by this paper
• Intestinal response to growth factors administered alone or in combination with human [Gly2]glucagon-like peptide 2.

  1997cited by this paper
• Upregulation of SGLT-1 transport activity in rat jejunum induced by GLP-2 infusion in vivo.

  1997cited by this paper
• Biological determinants of intestinotrophic properties of GLP-2 in vivo.

  1997cited by this paper
• Intestinal response to growth factors administered alone or in combination with human [Gly2]glucagon-like peptide 2.

  1997cited by this paper
• Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV

  1997cited by this paper
• Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2.

  1997cited by this paper
• Intestinal growth-promoting properties of glucagon-like peptide-2 in mice.

  1997cited by this paper
• Induction of intestinal epithelial proliferation by glucagon-like peptide 2.

  1996cited by this paper
• Regional expression of epithelial dipeptidyl peptidase IV in the human intestines.

  1994cited by this paper
• Proline-dependent structural and biological properties of peptides and proteins.

  1993cited by this paper
• Secretion of proglucagon-derived peptides in response to intestinal luminal nutrients.

  1991cited by this paper
• Renal catabolism of human glucagon-like peptides 1 and 2.

  1990cited by this paper
• Dipeptidyl peptidase (DPP) IV in rat organs

  1988cited by this paper
• Naturally occurring products of proglucagon 111-160 in the porcine and human small intestine.

  1988cited by this paper
• Transport and hydrolysis of glucagon in the proximal nephron.

  1986cited by this paper
• Hydrolysis and transport of small peptides by the proximal tubule.

  1980cited by this paper

• GLP‐2 and GIP acutely increase superior mesenteric artery blood flow in male rats, and the effect is independent of nitric oxide and vasoactive intestinal peptide

  2025cites this paper
• Effect of gut hormones on bone metabolism and their possible mechanisms in the treatment of osteoporosis

  2024cites this paper
• Glucagon-like peptide (GLP)-1 regulation of lipid and lipoprotein metabolism

  2024cites this paper
• Glucagon-Like Peptide-2 Ameliorates Age-Associated Bone Loss and Gut Barrier Dysfunction in Senescence-Accelerated Mouse Prone 6 Mice

  2022cites this paper
• Gut Hormones and Their Effect on Bone Metabolism. Potential Drug Therapies in Future Osteoporosis Treatment

  2019cites this paper
• Gut peptide and neuroendocrine regulation of hepatic lipid and lipoprotein metabolism in health and disease.

  2019cites this paper
• GLP-2 Dysregulates Hepatic Lipoprotein Metabolism, Inducing Fatty Liver and VLDL Overproduction in Male Hamsters and Mice.

  2018cites this paper
• GLP2: an underestimated signal for improving glycaemic control and insulin sensitivity.

  2016cites this paper
• Glucagon-like peptide-2 exhibits protective effect on hepatic ischemia-reperfusion injury in rats

  2015cites this paper
• Glugacon-like peptide-2: broad receptor expression, limited therapeutic effect on intestinal inflammation and novel role in liver regeneration.

  2014cites this paper
• The role of growth factors in intestinal regeneration and repair in necrotizing enterocolitis.

  2013cites this paper
• Dipeptidylpeptidase-IV, a key enzyme for the degradation of incretins and neuropeptides: activity and expression in the liver of lean and obese rats

  2012cites this paper
• The Acute Regulation of Intestinal Chylomicron Secretion by Glucagon-like Peptides

  2012cites this paper
• Intestinal mucosal atrophy and adaptation.

  2012cites this paper
• Compositions de peptide-2 de type glucagon et leurs procédés de fabrication et d'utilisation

  2012cites this paper
• Role of Glucagon-like Peptide-2 in Rodent Models of Colon Cancer

  2012cites this paper
• Effect of Glucagon-Like Peptide 2 on Hepatic, Renal, and Intestinal Disposition of 1-Chloro-2,4-dinitrobenzene

  2012cites this paper
• GLP-2 receptors in human disease: high expression in gastrointestinal stromal tumors and Crohn's disease.

  2012cites this paper
• Induction of Intestinal Multidrug Resistance-Associated Protein 2 by Glucagon-Like Peptide 2 in the Rat

  2010cites this paper
• GLP-2 Receptor Agonism Ameliorates Inflammation and Gastrointestinal Stasis in Murine Postoperative Ileus

  2010cites this paper
• Intestinal hormones and growth factors: effects on the small intestine.

  2009cites this paper
• IDENTIFICATION AND CHARA CTERIZATION OF THE GLUCAGON-LIKE PEPTIDE-2 HORMONAL SYSTEM IN RUMINANTS

  2009influential citation
• Exogenous glucagon-like peptide-2 (GLP-2) augments GLP-2 receptor mRNA and maintains proglucagon mRNA levels in resected rats.

  2008cites this paper
• Porcine glucagon-like peptide-2: structure, signaling, metabolism and effects.

  2008cites this paper
• Regulation of renal function by the gastrointestinal tract: potential role of gut-derived peptides and hormones.

  2008cites this paper
• Classical and novel hormonal influences on renal tubular transport and the emerging concept of intracrine regulation.

  2007cites this paper
• Review article: glucagon‐like peptide 2 – current applications and future directions

  2007cites this paper
• The role of polyamines in glucagon-like peptide-2 prevention of TPN-induced gut hypoplasia.

  2006cites this paper
• Glucagon-Like Peptide-2 in Umbilical Cord Blood from Mature Infants

  2006cites this paper
• Glucagon-like peptide 2 (GLP-2), an intestinotrophic mediator.

  2004cites this paper
• Supplementation of total parenteral nutrition with butyrate acutely increases structural aspects of intestinal adaptation after an 80% jejunoileal resection in neonatal piglets.

  2004cites this paper
• An unusual case of abdominal pain

  2004cites this paper
• Experimental Studies on the Control of Food Intake

  2003cites this paper
• Glucagon-like peptide 2 function in domestic animals.

  2003cites this paper
• Peripheral administration of GLP-2 to humans has no effect on gastric emptying or satiety.

  2003cites this paper
• International Union of Pharmacology. XXXV. The Glucagon Receptor Family

  2003cites this paper
• Immunoneutralization of endogenous glucagon-like peptide-2 reduces adaptive intestinal growth in diabetic rats.

  2002cites this paper
• The truncated metabolite GLP-2 (3-33) interacts with the GLP-2 receptor as a partial agonist.

  2002cites this paper
• Glucagon-like peptide 2: a nutrient-responsive gut growth factor.

  2001cites this paper
• Recent Advances in Nutritional Sciences Glucagon-Like Peptide 2 : A Nutrient-Responsive Gut Growth Factor 1 , 2 , 3

  2001cites this paper